Haemonetics CorporationHAENYSE
Loading
Year-over-year net income growth rate
Percentile
P59
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 15.66% |
| Q3 2025 | 13.67% |
| Q2 2025 | -41.31% |
| Q1 2025 | 54.64% |
| Q4 2024 | 10.83% |
| Q3 2024 | -11.84% |
| Q2 2024 | 88.41% |
| Q1 2024 | -34.81% |
| Q4 2023 | 25.43% |
| Q3 2023 | -39.31% |
| Q3 2023 | 39.68% |
| Q1 2023 | -10.81% |
| Q4 2022 | -0.76% |
| Q4 2022 | 67.01% |
| Q3 2022 | 104.06% |
| Q1 2022 | -58.07% |
| Q1 2022 | 56.38% |
| Q4 2021 | 433.54% |
| Q3 2021 | 59.66% |
| Q1 2021 | -134.63% |
| Q4 2020 | -33.72% |
| Q3 2020 | 356.93% |
| Q2 2020 | -40.27% |
| Q1 2020 | -41.05% |
| Q4 2019 | -20.25% |
| Q3 2019 | 542.10% |
| Q2 2019 | -140.70% |
| Q1 2019 | 14.00% |
| Q4 2018 | -2.40% |
| Q3 2018 | 764.28% |
| Q2 2018 | -123.73% |
| Q1 2018 | 281.46% |
| Q4 2017 | -132.57% |
| Q3 2017 | -0.17% |
| Q3 2017 | 139.38% |
| Q1 2017 | -432.23% |
| Q4 2016 | -22.36% |
| Q4 2016 | 291.62% |
| Q3 2016 | -17.89% |
| Q1 2016 | 85.24% |